|
Hydrogenated Soybean Oil
» Hydrogenated Soybean Oil is the product obtained by refining, bleaching, hydrogenation, and deodorization of oil obtained from seeds of the soya plant Glycine max Merr. (Fabaceae). The product consists mainly of triglycerides of palmitic and stearic acids.
Packaging and storage
Preserve in tight, light-resistant containers. No storage requirements specified.
Identification
A:
It meets the requirements of the test for Fatty acid composition.
B:
It meets the requirements of the test for Melting range.
Acid value
Peroxide value
Unsaponifiable matter
Fatty acid composition
Alkaline impurities
Dissolve by gently heating 2.0 g of Hydrogenated Soybean Oil in a mixture of 1.5 mL of alcohol and 3.0 mL of toluene. Add 0.05 mL of bromophenol blue TS, and titrate with 0.01 N hydrochloric acid VS to a yellow endpoint: not more than 0.4 mL of 0.01 N hydrochloric acid is required.
Water, Method I
Limit of nickel
Test solution
Weigh 5.0 g of Hydrogenated Soybean Oil into a previously tared platinum or silica crucible. Cautiously heat, and introduce into the substance a wick formed from twisted ashless filter paper. Ignite the wick. When the substance ignites, stop heating. After combustion, ignite in a muffle furnace at about 600
Nickel standard solution
Immediately before use, dilute 10 mL of nickel standard solution TS with water to 500 mL. This solution contains the equivalent of 0.2 µg of nickel per g.
Standard solutions
Into three identical 10-mL volumetric flasks, introduce respectively 1.0 mL, 2.0 mL, and 4.0 mL of Nickel standard solution. To each flask, add a 2.0-mL portion of the Test solution, and dilute with water to volume.
Procedure
Concomitantly determine the absorbances of the Standard solutions and the Test solution at least three times each, at the wavelength of maximum absorbance at 232.0 nm, with a suitable atomic absorption spectrophotometer (see Spectrophotometry and Light-Scattering
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 1353
Pharmacopeial Forum: Volume No. 30(3) Page 995
|